BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 17531918)

  • 1. Arterial-wave reflections are increased in heart failure patients with a left-ventricular assist device.
    Schofield RS; Pierce GL; Nichols WW; Klodell CT; Aranda JM; Pauly DF; Hill JA; Braith RW
    Am J Hypertens; 2007 Jun; 20(6):622-8. PubMed ID: 17531918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy: a subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure).
    Stevenson LW; Miller LW; Desvigne-Nickens P; Ascheim DD; Parides MK; Renlund DG; Oren RM; Krueger SK; Costanzo MR; Wann LS; Levitan RG; Mancini D;
    Circulation; 2004 Aug; 110(8):975-81. PubMed ID: 15313942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cuff and aortic pressure differences during dobutamine infusion: a study of the effects of systolic blood pressure amplification.
    Smulyan H; Mukherjee R; Sheehe PR; Safar ME
    Am Heart J; 2010 Mar; 159(3):399-405. PubMed ID: 20211301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed reversal of impaired metabolic vasodilation in patients with end-stage heart failure during long-term circulatory support with a left ventricular assist device.
    Khan T; Levin HR; Oz MC; Katz SD
    J Heart Lung Transplant; 1997 Apr; 16(4):449-53. PubMed ID: 9154956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between radial and central arterial pulse wave and evaluation of central aortic pressure using the radial arterial pulse wave.
    Takazawa K; Kobayashi H; Shindo N; Tanaka N; Yamashina A
    Hypertens Res; 2007 Mar; 30(3):219-28. PubMed ID: 17510503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of recurrent heart failure associated with left ventricular assist device dysfunction.
    Jaski BE; Miller DA; Hoagland PM; Gordon JB; Chillcott SR; Stahovich MJ; Adamson RM; Baradarian S; Dembitsky WP
    J Heart Lung Transplant; 2005 Dec; 24(12):2060-7. PubMed ID: 16364850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of continuous aortic flow augmentation in patients with exacerbation of heart failure inadequately responsive to medical therapy: results of the Multicenter Trial of the Orqis Medical Cancion System for the Enhanced Treatment of Heart Failure Unresponsive to Medical Therapy (MOMENTUM).
    Greenberg B; Czerska B; Delgado RM; Bourge R; Zile MR; Silver M; Klapholz M; Haeusslein E; Mehra MR; Mather P; Abraham WT; Neaton JD; Brown BS; Parker IC; Konstam MA;
    Circulation; 2008 Sep; 118(12):1241-9. PubMed ID: 18765394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of dobutamine versus milrinone therapy in hospitalized patients awaiting cardiac transplantation: a prospective, randomized trial.
    Aranda JM; Schofield RS; Pauly DF; Cleeton TS; Walker TC; Monroe VS; Leach D; Lopez LM; Hill JA
    Am Heart J; 2003 Feb; 145(2):324-9. PubMed ID: 12595851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initial experience with miniature axial flow ventricular assist devices for postcardiotomy heart failure.
    Jurmann MJ; Siniawski H; Erb M; Drews T; Hetzer R
    Ann Thorac Surg; 2004 May; 77(5):1642-7. PubMed ID: 15111158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulse wave analysis of the aortic pressure waveform in severe left ventricular systolic dysfunction.
    Denardo SJ; Nandyala R; Freeman GL; Pierce GL; Nichols WW
    Circ Heart Fail; 2010 Jan; 3(1):149-56. PubMed ID: 19903930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of submaximal exercise capacity in patients with left ventricular assist devices.
    Foray A; Williams D; Reemtsma K; Oz M; Mancini D
    Circulation; 1996 Nov; 94(9 Suppl):II222-6. PubMed ID: 8901750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial.
    Rogers JG; Butler J; Lansman SL; Gass A; Portner PM; Pasque MK; Pierson RN;
    J Am Coll Cardiol; 2007 Aug; 50(8):741-7. PubMed ID: 17707178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left ventricular assist device support of medically unresponsive pulmonary hypertension and aortic insufficiency.
    Adamson RM; Dembitsky WP; Jaski BE; Daily PO; Moreno R; Kim JC; Sono J; Akasaka T; Hoagland PM; Gordon JB
    ASAIO J; 1997; 43(4):365-9. PubMed ID: 9242955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of centrifugal, axial, and pulsatile left ventricular assist device support on end-organ function in heart failure patients.
    Kamdar F; Boyle A; Liao K; Colvin-adams M; Joyce L; John R
    J Heart Lung Transplant; 2009 Apr; 28(4):352-9. PubMed ID: 19332262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of the percutaneous left ventricular assist device in patients with severe refractory cardiogenic shock as a bridge to long-term left ventricular assist device implantation.
    Idelchik GM; Simpson L; Civitello AB; Loyalka P; Gregoric ID; Delgado R; Kar B
    J Heart Lung Transplant; 2008 Jan; 27(1):106-11. PubMed ID: 18187095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between wasted pressure effort and left ventricular hypertrophy in hypertension: influence of arterial wave reflection.
    Hashimoto J; Nichols WW; O'Rourke MF; Imai Y
    Am J Hypertens; 2008 Mar; 21(3):329-33. PubMed ID: 18202668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical measurement of arterial stiffness obtained from noninvasive pressure waveforms.
    Nichols WW
    Am J Hypertens; 2005 Jan; 18(1 Pt 2):3S-10S. PubMed ID: 15683725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left ventricular assist device therapy in patients with restrictive and hypertrophic cardiomyopathy.
    Topilsky Y; Pereira NL; Shah DK; Boilson B; Schirger JA; Kushwaha SS; Joyce LD; Park SJ
    Circ Heart Fail; 2011 May; 4(3):266-75. PubMed ID: 21303989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of angiotensin-converting enzyme inhibitor therapy on the extracellular collagen matrix during left ventricular assist device support in patients with end-stage heart failure.
    Klotz S; Danser AH; Foronjy RF; Oz MC; Wang J; Mancini D; D'Armiento J; Burkhoff D
    J Am Coll Cardiol; 2007 Mar; 49(11):1166-74. PubMed ID: 17367660
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arterial stiffness, central blood pressures, and wave reflections in cardiomyopathy-implications for risk stratification.
    Weber T; Auer J; Lamm G; O'Rourke MF; Eber B
    J Card Fail; 2007 Jun; 13(5):353-9. PubMed ID: 17602981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.